Registration Coming Soon!
Course Description
Join us as we dissect the practice-changing developments from the 2026 ASCO Annual Meeting and contextualize them within the landscape of your current clinical practice in hematology and oncology. Our comprehensive agenda spans the full spectrum of cancer types. Gain practical insights and actionable strategies that seamlessly integrate into your clinical practice, enhancing your ability to provide unparalleled patient care.
Don't miss this opportunity to be at the forefront of change. Register now and take your practice to new heights.
Target Audience
This activity is designed for physicians and other healthcare professionals caring for patients with solid organ malignancies or hematologic malignancies.
Location
Hilton Chicago/Oak Brook Hills Resort & Conference Center
3500 Midwest Road
Oak Brook, IL 60523
Learning Objectives:
After this activity, participants will be able to:
Recall key ASCO 2026 practice-changing updates in the treatment of solid and hematologic malignancies.
Describe evidence-based strategies to manage toxicities associated with novel therapies in solid and hematologic malignancies.
Interpret the indications and clinical applications of next-generation sequencing (NGS) in tumor profiling reports to guide personalized cancer therapy.
Integrate recent ASCO 2026 evidence into individualized patient management plans to optimize cancer care and survivorship.
Apply key findings from ASCO 2026 to multidisciplinary clinical decision-making in real-world oncology practice.
Course Directors
Nan Chen, MD
Assistant Professor of Medicine
University of Chicago Medicine
Chih-Yi Liao, MD
Associate Professor of Medicine
University of Chicago Medicine